Skip to main content

Alejandro Armando Peláez Suárez

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca
Alejandro Armando Peláez Suárez

Alejandro Armando Peláez Suárez

Alejandro Armando Peláez Suárez

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

A study conducted at the Catalan Multiple Sclerosis Centre (Cemcat) shows that the lack of a reduction in neurofilament light chain during the first year of treatment is associated with a higher risk of subsequent disease activity.

The project’s 4th annual meeting was recently held as part of the Fortalece–Salud programme of the Carlos III Health Institute.

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

Related professionals

Ángeles Mesas Idáñez

Ángeles Mesas Idáñez

Clinical Pharmacology
Read more
Olga Fernandez Redo

Olga Fernandez Redo

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Núria Gallardo Hernández

Núria Gallardo Hernández

Research technician
Psychiatry, Mental Health and Addictions
Read more
David Téllez Velasco

David Téllez Velasco

Research technician
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.